Executive Order 202.44 and Clinical Laboratories
Executive Order 202.44 issued on June 21, 2020 continues to modify various provisions of the law to address the COVID-19 pandemic. The first modification permits clinical laboratories to “accept and examine specimens for COVID-19 testing from nursing home and adult care facilities personnel without a prescription or order and to report tests to the appropriate staff at the facilities. It also requires the facilities to report to the local department of health any positives results received.
New York usually requires clinical laboratories to only accept specimens at the request of licensed physicians or other persons as authorized by law and to report directly to the ordering physician or authorized person. See N.Y. Pub Health Law § 576-b(1) and 10 N.Y.C.R.R. § 58-1.7. Such modification as it relates to COVID-19 is currently in effect until July 21, 2020.
In addition, the Executive Order is also allowing licensed pharmacists to order and administer COVID tests or test for its antibodies and to direct limited service laboratories as it relates to COVID-19. This amends N.Y. Pub Health Law § 571(6) and N.Y. Education Law § 680.
For more information, please contact Jeffrey J. Sherrin at jsherrin@oalaw.com or Samantha L. Femia at sfemia@oalaw.com.
More Articles You May Enjoy
ATTENTION MEDICARE PROVIDERS: Important Revisions to the 60 Day Overpayment Repayment and Report Rule
What is the so-called 60 day Overpayment and Report Rule (“the 60-day rule”) and where […]
Read PostThe New York State PACE Program: A Guide for Providers
As uncertainty in the healthcare industry persists, programs that integrate medical and long-term care services […]
Read PostHHS Issues Guidance Notice for Skilled Nursing Facilities and Nursing Homes
ATTENTION NURSING FACILITIES: On November 20, 2024, the U.S. Department of Health and Human Services […]
Read Post